Nous avons 56 finalistes de 17 pays.<\/p>\n
Les finalistes pour le Lush Prize 2018 sont:<\/p>\n
<\/p>\n
L2: Dr Siavash Ahmadi Noorbakhsh<\/strong> L3: Partei Mensch Umwelt Tierschutz (Tierschutzpartei) [Animal Welfare Party]<\/strong> L4: Rescue + Freedom Project<\/strong> L5: White Coat Waste Project<\/strong> L6: People for the Ethical Treatment of Animals, Laboratory Investigations Department<\/strong> L7: Brazilian Network for Humane Education (RedEH)<\/strong> <\/p>\n PA2: Doctors Against Animal Experiments<\/strong> PA3: Animal Justice Project<\/strong> PA4: Dalian Vshine Animal Protection Association<\/strong> PA5: Beagle Rescue Network<\/strong> PA6: Stichting Proefdiervrij<\/strong> PA7: Humane Research Australia<\/strong> PA8: White Coat Waste Project<\/strong> <\/p>\n S2: cellasys GmbH<\/strong> S3: Prof Yeong Wai Yee – Nanyang Technological University<\/strong> S4: Dr Ellen Berg<\/strong> S5: Dr Kyung-Min Lim<\/strong> S6: Dr Bruno Neves<\/strong> S7: BASF Experimental Toxicology and Ecology<\/strong> S8: Johns Hopkins CAAT \/ UL<\/strong> S9: Dr Jiangwa Xing<\/strong> S10: Dr Dan Huh, The BIOLines Research Group, University of Pennsylvania<\/strong> <\/p>\n T2: SYRCLE (Systematic Review Centre for Laboratory Experimentation \u2013 Department for Health Evidence Radboud university medical center)<\/strong> T3: FCS-free database team, 3Rs-Centre Utrecht Life Sciences<\/strong> T4: Guangzhou Chn-Alt Center for Alternative Research & Evaluation<\/strong> T5: MatTek In Vitro Life Science Laboratories<\/strong> T6: Ms Kumiko Tatsumi<\/strong> <\/p>\n YR-Asia-2:\u00a0 Ms Jee-hyun Hwang<\/strong> YR-Asia-3: Ms Hyunah Moon<\/strong> YR-Asia-4:Ms Qianqian Wang<\/strong> YR-Asia-5:Dr Jiangwa Xing<\/strong> YR-Asia-6:Mr Ye Dong Jin<\/strong> YR-Asia-7:Ms Miri Lee<\/strong> YR-Asia-8:Mr Kota Toshimoto<\/strong> <\/p>\n YR-Americas-2: Dr Michelle Sabrina Silva<\/strong> YR-Americas-3: Dr Natalia Sizochenko<\/strong> YR-Americas-4: Dr Vinicius Alves<\/strong> YR-Americas-5: Mr Sasan Jalili Firoozinezhad<\/strong> YR-Americas-6: Dr Pilar de la Puente<\/strong> <\/p>\n YR-RoW-2: Dr Alessandro Polini<\/strong> YR- RoW-3: Dr Arutha Kulasinghe<\/strong> YR- RoW-4: Ms Parul Chandorkar<\/strong> YR- RoW-5: Mr Thomas Kralj<\/strong> YR- RoW-6: Dr Daniel Urbisch<\/strong> YR-RoW-7: Mr Nikolas Gaio<\/strong> YR-RoW-8: Ms Alexandra Damerau<\/strong> YR-RoW-9: Mr Sebastian Eggert<\/strong> YR-RoW-10: Dr Francesca Grisoni<\/strong> YR-RoW-11: Ms Isabel R\u00fctschle<\/strong> Nous avons 56 finalistes de 17 pays. Les finalistes pour le Lush Prize 2018 sont: Lobbying L1: Dr Jeoung Ae Han, Member of National Assembly South Korea Passage of major chemical law (K-REACH) reform requiring prioritization of 1R replacement alternatives to animal testing L2: Dr Siavash Ahmadi Noorbakhsh Iran Promotion of using replacement […]<\/p>\n","protected":false},"author":88892,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-25451","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\n
\nL1: Dr Jeoung Ae Han, Member of National Assembly<\/strong>
\nSouth Korea
\nPassage of major chemical law (K-REACH) reform requiring prioritization of 1R replacement alternatives to animal testing<\/p>\n
\nIran
\nPromotion of using replacement methods in biomedical research in Iran<\/p>\n
\nGermany
\nTierrechte in die Parlamente, Tierversuche verbieten [Animal Rights in Parliament \u2013 Banning Animal Testing]<\/p>\n
\nUSA
\nLobbying for Life<\/p>\n
\nUSA
\nWCW Federal Lobbying 2017-2018<\/p>\n
\nUSA
\nReplacing Animal Use in Global Military and Civilian Trauma Training<\/p>\n
\nBrazil
\nEnd of animal use for demonstration purposes on learning for 2019, being Brazil the first country on Latin America banning animal classes<\/p>\n
\nSensibilisation du public<\/h2>\n
\nPA1: National Anti-Vivisection Society<\/strong>
\nUSA
\nPublic Awareness Initiatives<\/p>\n
\nGermany
\nPromoting Science instead of Animal Experiments<\/p>\n
\nUK
\nCampus Without Cruelty<\/p>\n
\nChina
\nLoss of experimental animals – the pain of experimental animals, you can never empathy!<\/p>\n
\nSouth Korea
\nAmendment of Laboratory Animal Law in S.Korea<\/p>\n
\nNetherlands
\nMonkey see, monkey do: spreading the word about animal-free research innovations<\/p>\n
\nAustralia
\nEnding animal experiments<\/p>\n
\nUSA
\nWCW Public Awareness Campaign<\/p>\n
\nScience<\/h2>\n
\nS1: Alcyomics Ltd<\/strong>
\nUK
\nIN VITRO \u201cskin patch tests\u201d for the detection of sensitization, allergy and relative potency assessment<\/p>\n
\nGermany
\nSkin-on-a-Chip<\/p>\n
\nSingapore
\nBioprinting of tissue models<\/p>\n
\nUSA
\nPhenotypic chemical biology for predicting safety and efficacy<\/p>\n
\nSouth Korea
\nIn vitro irritation tests with Korean 3D tissue models<\/p>\n
\nPortugal
\nDevelopment of non-animal alternative approach for chemical skin sensitization risk assessment<\/p>\n
\nGermany
\nAOP-based testing strategy for the prediction of skin sensitization: the ‘2 out of 3’ approach<\/p>\n
\nUSA
\nRead-Across-based Structure Activity Relationships<\/p>\n
\nChina
\nIn vitro micropatterned human pluripotent stem cell test for teratogen screening<\/p>\n
\nUSA
\nMicroengineered bio-mimicry of human physiological systems<\/p>\n
\nFormation<\/h2>\n
\nT1: Laboratory of Education and Research in Pharmacology and Cellular Toxicology, LPCT Team<\/strong>
\nBrazil
\nDisseminating Alternative Methods in Brazil and South America: Education and Training for Animal Replacement in Science<\/p>\n
\nNetherlands
\nTraining in systematic reviews of preclinical studies<\/p>\n
\nNetherlands
\nFCS-free Database<\/p>\n
\nChina
\nTraining platform for industries and academic consensus for replacement animal in China<\/p>\n
\nSlovakia
\nHands-on training and Teaching on Alternative Methods in Toxicology<\/p>\n
\nJapan
\nTraining of primary cell culture using residual resected human tissue<\/p>\n
\nJeunes chercheurs – Asie<\/h2>\n
\nYR-Asia-1:\u00a0Dr Guan-Yu Chen<\/strong>
\nTaiwan
\nDevelopment of a new assessment model for health effects of particulate matter<\/p>\n
\nSouth Korea
\nInvestigation of dermal toxicity using alternative methods to animal testing<\/p>\n
\nSouth Korea
\nDevelopment of reconstituted human skin models for testing the safety and efficacy of cosmetic and pharmaceutical substances<\/p>\n
\nChina
\nApplication of in-vitro techniques to investigate the pharmacological and toxicological effects of arsenicals<\/p>\n
\nChina
\nTeratogenic mechanism study of tyrosine kinase inhibitors using the micropatterned human pluripotent stem cell test (\u00b5P-hPST) assay<\/p>\n
\nSouth Korea
\nDiscovery of Ezrin Expression as a Potential Biomarker for Chemically Induced Ocular Irritation Using Human Corneal Epithelium Cell Line and a Reconstructed Human Cornea-like Epithelium Model<\/p>\n
\nSouth Korea
\nLipid caring<\/p>\n
\nJapan
\nPrediction in silico of major clearance pathway of drugs in vivo<\/p>\nJeunes chercheurs – Am\u00e9riques<\/h2>\n
\nYR-Americas-1: Ms Lorena Neves<\/strong>
\nBrazil
\nUsing Polyvinylpyrrolidone (PVP) as an alternative to animal inputs in the Western blotting protocol<\/p>\n
\nBrazil
\nUse of human scalp as a tool for advances in hair science and understanding of disorders and pathologies associated with extrinsic and intrinsic factors – a replacement for experimental models of non-human animals<\/p>\n
\nUSA
\nWhen a foe becomes a friend: Staphylococcal autolysins as next generation antibiotics<\/p>\n
\nUSA
\nDevelopment of an artificial intelligence-based web platform for early toxicity assessment of mixtures present in major classes of industrial chemicals<\/p>\n
\nUSA
\nModeling radiation injury and countermeasure drug responses in a human Intestine Chip co-cultured with complex human gut microbiome<\/p>\n
\nUSA
\nPatient-derived in vitro breast cancer model for personalized in vitro drug screening<\/p>\nJeunes chercheurs \u2013 Reste du monde<\/h2>\n
\nYR-RoW-1: Ms Aline Chary<\/strong>
\nLuxembourg
\nImplementation of 1R principle for an in vitro alveolar model<\/p>\n
\nItaly
\nNeuromuscular junction-on-a-chip models for the study of Amyotrophic Lateral Sclerosis (ALS) disease<\/p>\n
\nAustralia
\nEx vivo expansion of patient derived circulating tumour cells<\/p>\n
\nAustria
\nEstablishment of an invitro 3D human lung model to study fungal infections<\/p>\n
\nAustralia
\nIn vitro identification and prediction of drug induced liver toxicity through use of metabolomic analysis<\/p>\n
\nGermany
\nReplacement of animal testing: Evaluation of non-animal methods for assessing skin sensitization<\/p>\n
\nNetherlands
\nReplacing animal tests with silicon chips<\/p>\n
\nGermany
\nMimicking arthritis in vitro – a multicomponent model<\/p>\n
\nAustralia
\nFacilitating animal free precision cancer medicine: development and evaluation of an automated manufacturing and screening platform for personalized 3D cancer models<\/p>\n
\nItaly
\n\u00ab\u00a0Artificially intelligent\u00a0\u00bb integrated replacement of animal eye irritation tests<\/p>\n
\nGermany
\nInvestigating effects of substances on co-cultures of human three-dimensional bronchial models and liver models using a Multi-Organ-Chip approach<\/p>\n","protected":false},"excerpt":{"rendered":"